Lambiase R E, Deyoe L, Cronan J J, Dorfman G S
Department of Diagnostic Imaging, Rhode Island Hospital, Providence.
Radiology. 1992 Jul;184(1):167-79. doi: 10.1148/radiology.184.1.1376932.
Retrospective review of percutaneous abscess drainage (PAD) of 335 abscesses in 323 consecutive patients was undertaken. Particular attention was directed to body location, associated organ system, communications and fistulae, and to the underlying immunologic status of the patient. One-year follow-up was available in all patients. Overall, the cure rate was 62.4% (209 of 335 abscesses), with a failure rate of 8.95% (30 of 335 abscesses). There were 14.2% (46 of 323 patients) deaths in the follow-up period, of which 4.6% (15 of 323 patients) were believed attributable to sepsis or septic complications. The overall complication rate was 9.8% (33 of 335 abscesses), most of which were minor in nature. For the patient exhibiting immunocompromise, representing 53.1% (172 of 323 patients) of the patient population, the cure rate was 53.4% (95 of 178 abscesses), which was significantly lower than the cure rate of 72.6% (114 of 157 abscesses) for the immunocompetent patient population (n = 151) (P less than .001). The recurrence rate was 2.1% (seven of 335 abscesses), with all recurrences within 3 months of initial drainage. PAD is effective and permanent treatment for both immunocompromised and immunocompetent patients.
对323例连续患者的335处脓肿进行经皮脓肿引流（PAD）的回顾性研究。特别关注脓肿的身体部位、相关器官系统、连通情况和瘘管，以及患者的基础免疫状态。所有患者均进行了为期一年的随访。总体而言，治愈率为62.4%（335处脓肿中的209处），失败率为8.95%（335处脓肿中的30处）。随访期间有14.2%（323例患者中的46例）死亡，其中4.6%（323例患者中的15例）被认为归因于败血症或脓毒症并发症。总体并发症发生率为9.8%（335处脓肿中的33处），大多数并发症性质较轻。对于免疫功能低下的患者，占患者总数的53.1%（323例患者中的172例），治愈率为53.4%（178处脓肿中的95处），显著低于免疫功能正常患者群体（n = 151）的治愈率72.6%（157处脓肿中的114处）（P < 0.001）。复发率为2.1%（335处脓肿中的7处），所有复发均发生在初次引流后的3个月内。PAD对免疫功能低下和免疫功能正常的患者都是一种有效且持久的治疗方法。
